Guangxi Wuzhou Communications Co Ltd

Guangxi Wuzhou Communications Co., Ltd.'s controlling shareholder, Guangxi Communications Investment Group Co., Ltd., plans to increase its shareholding in the company over the next 12 months, with the proposed increase amounting to no less than 89.045 million yuan and no more than 178.09 million yuan. According to the announcement, the share increase plan will be implemented within 12 months starting from October 8, 2026. Guangxi Communications Investment Group will increase its holdings of the company's A-shares through centralized bidding on the Shanghai Stock Exchange, with the increase not exceeding 2% of the company's total share capital. No price range is set for the share increase, and the funding source is its own funds or other lawful sources of funds. Before the increase, Guangxi Communications Investment Group held 618,948,686 shares of Wuzhou Communications, accounting for 38.45% of the company's total share capital, making it the controlling shareholder. The announcement also disclosed that from September 15, 2025 to September 3, 2026, Guangxi Communications Investment Group had cumulatively increased its holdings by 32,193,000 shares, accounting for approximately 2% of the company's total share capital, with a cumulative increase amount of 135,361,758.24 yuan, and that increase plan has been completed. In the six months prior to this announcement, the entity increasing holdings had no reduction in holdings. Guangxi Communications Investment Group undertakes not to reduce its holdings in the company within 12 months after the completion of the share increase plan and within the statutory period, and notes that this increase may be unable to be implemented or completed on schedule due to changes in the capital market environment, policy adjustments, or other unforeseeable factors.

On the final day of the National Day holiday, multiple listed companies issued positive announcements and risk warnings. Huahai Pharmaceutical announced that net profit attributable to shareholders of the listed company for the first three quarters of 2026 is expected to be between 1.028 billion yuan and 1.103 billion yuan, up 170% to 190% year on year, mainly due to a substantial increase in sales revenue from its active pharmaceutical ingredients business, expansion of products winning centralized procurement bids in the domestic formulations business, a turnaround to profitability in its US formulations business, gains from winning an arbitration case, and a reduction in research and development expenses. ZSP1601 tablets, a Class 1 innovative drug independently developed by Zhongshan Ruichuang, a controlling subsidiary of Zhongsheng Pharmaceutical, has been accepted into the breakthrough therapy designation procedure by the Center for Drug Evaluation of the National Medical Products Administration, with the proposed indication being metabolic dysfunction-associated steatohepatitis. The drug is a first-in-class innovative drug with global independent intellectual property rights. Yahong Medical signed a conditional exclusive licensing agreement with Theramex, under which Theramex will obtain exclusive rights to APL-1702 in European countries as well as Australia, New Zealand, and Turkey. Yahong Medical will receive an upfront payment of 15 million US dollars, a near-term regulatory milestone payment of 11 million US dollars, commercial milestone payments, and tiered sales royalties, with the total transaction value exceeding 250 million US dollars. Wuzhou Communications' controlling shareholder, Jiaotou Group, plans to increase its shareholding in the company within 12 months starting from October 8, 2026, with the proposed increase amount being no less than 89.045 million yuan and no more than 178 million yuan. Du Jinhao, the actual controller, chairman, and general manager of Allist, proposed that the company use its own funds to repurchase some A-shares, with the total repurchase amount being no less than 100 million yuan and no more than 200 million yuan. BYD Company announced on the Hong Kong Stock Exchange that its new energy vehicle sales in September were 463,561 units, up 16.98% year on year. On the same day, Feilong Auto Parts estimated that its net profit for the first three quarters of 2026 would be between 95 million yuan and 117 million yuan, down 59.20% to 66.87% year on year. Zhongke Haixun was banned by the naval procurement management department from participating in naval materials, engineering, and service procurement activities from September 23, 2026 to September 23, 2027, due to bid rigging and collusion violations in a certain assessment system procurement project. Zheng Chuangfa, the controlling shareholder and actual controller of Guanghua Technology, plans to reduce his shareholding by no more than 14.0581 million shares, or no more than 3% of the company's total share capital. Shi Zhongwei, the actual controller of Zhongya Stock, and his concert parties plan to reduce their combined shareholding by no more than 11.779 million shares.

The review status of Wuzhou Communications' public offering of convertible bonds application has changed to registration effective. The company plans to issue convertible bonds to unspecified investors, with expected proceeds of 3 billion yuan, and the sponsor is Guotai Haitong Securities.

Wuzhou Communications announced that its 500 million yuan short-term notes have been approved for registration by the National Association of Financial Market Institutional Investors. The registration quota is valid for two years from the date of the notice, with China Minsheng Bank and Shanghai Pudong Development Bank acting as joint lead underwriters. The company may issue the notes in tranches within the registration validity period, and manage the issuance in accordance with resolutions of authorized bodies and relevant management requirements.